Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of the NULISAseq Neuro 220 Panel with ...

Join Alamar Biosciences for an expert-led webinar exploring how emerging proteomics technologies—like NULISAseq™ high-sensitivity, multiplexed assays—are enabling more precise, scalable, and ...

The successful translation of biomarker discoveries into actionable diagnostic tools requires strict adherence to the robust regulations governing clinical proteomics. As mass spectrometry and ...

The integration of proteomics in biomarker discovery represents a major advancement in molecular diagnostics and precision medicine. Researchers seek highly specific indicators of complex disease ...

Humans have approximately 20,000 human protein-coding genes, and the proteins they express span a concentration range of ~12 logs. Yet only 0.1% of proteins contribute to 99% of the total plasma ...

Associate Professor, Director of the Microscopy and Cytometry Core Facility at Amsterdam UMC and Co-Director of the Immune Monitoring Unit at the Amsterdam UMC Immunotherapy Center Multiplexed ...

InDevR, Inc., a leader in analytical solutions for vaccine in-process and quality control testing, and Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ...

In a recent study published in Nature Communications, researchers combined mass spectrometry-based proteomic phenotyping with machine learning to identify blood biomarkers in early Parkinson's disease ...

Golden, CO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) ...

Incidence and co-occurrence of targetable key genomic alterations (GenAlt) in metastatic prostate cancer (mPC): Preliminary results from the prostate cancer cohort of the FPG500 program. This is an ...

Even the most die-hard genomics aficionados can admit that proteomics is having a moment: researchers are asking more protein-based questions to uncover new biology. For example, Anne Carpenter, PhD, ...